The Innovation Explorer database of GlobalData’s Disruptor Intelligence Center highlights the key company collaborations in pharma to advance AI-powered drug repurposing techniques.
New CE-marked algorithm for the Azurion platform delivers improved image quality with over 50% lower radiation dose compared to the lowest settings on ClarityIQ
Union Health Minister highlights India’s progress in universal health coverage, digital health, AI strategy and global vaccine cooperation during plenary session in Geneva
The platform combines internally developed technologies, strategic partnerships, and external AI capabilities
Union Minister Prataprao Jadhav terms hypertension a “silent killer”; experts push for early screening, lifestyle correction and wellness-focused healthcare
The company’s shares of confidence were underlined by an upgraded 2026 outlook, with Merck now expecting annual net sales of up to €21.4 billion and EBITDA pre of as much as €6.1 billion
Investment will support LifeSigns’ global expansion across Southeast Asia and GCC markets
The ultrasound-based AI imaging platform is designed to support rapid fracture detection and soft tissue injury assessment in emergency care settings
Mumbai event on June 24–25 will spotlight real-world impact of pharmacovigilance beyond AI adoption
The acquisition positions Roche more aggressively in digital pathology and precision diagnostics capabilities
Subscribe To Our Newsletter & Stay Updated
